Medical Devices Europe

Europe Biological Age Testing Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Europe Biological Age Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Europe · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $187.7 Mn Placeholder estimate
Estimate 2025 $209.2 Mn 20.5% of the global market
Projected 2034 $557.3 Mn 166.4% Adds $348.1 Mn over 9 forecast years
CAGR 2025–2034 11.5% Faster than 83% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Europe is 20.48% of the global market.
  • Among regions, the largest is North America at $520.1 Mn.
  • Fastest growing: Latin America at 14.3% a year.
  • Europe ranks 3rd of 6 by size among regions.

Market size projection

Europe

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$348.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Biological Age Testing Market market size by year, Europe
YearMarket sizeChange that yearSince 2025
2024 (estimate) $187.7 Mn — —
2025 (base) $209.2 Mn +$21.6 Mn —
2026 (forecast) $233.3 Mn +$24.1 Mn +11.5%
2027 (forecast) $260.1 Mn +$26.8 Mn +24.3%
2028 (forecast) $290.0 Mn +$29.9 Mn +38.6%
2029 (forecast) $323.4 Mn +$33.4 Mn +54.6%
2030 (forecast) $360.6 Mn +$37.2 Mn +72.3%
2031 (forecast) $402.1 Mn +$41.5 Mn +92.2%
2032 (forecast) $448.3 Mn +$46.2 Mn +114.3%
2033 (forecast) $499.8 Mn +$51.6 Mn +138.9%
2034 (forecast) $557.3 Mn +$57.5 Mn +166.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Europe Biological Age Testing Market Analysis at a glance
Market size, 2025$209.2 Mn placeholder estimate
Forecast, 2034$557.3 Mn placeholder estimate
Growth (CAGR), 2025–203411.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest, channel and end user (see all)
Key playersTruDiagnostic, Tally Health, InsideTracker, GlycanAge, Elysium Health (see all)
Regulator in EuropeEU MDRSource: European Commission, medical devices. Checked 14 Nov 2026.
Active clinical trials29 in EuropeSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Europe Biological Age Testing Market Analysis Executive Summary

Biological age tests estimate how fast a person is ageing using DNA methylation, blood markers or other data, rather than their age in years.

Key segments of the biological Age Testing market include test (Epigenetic Clocks, Blood Biomarker Panels and Telomere Tests) and channel (Direct-to-Consumer, Clinics and Research).

Bar chart: Europe Biological Age Testing market size, 2024–2034, placeholder estimates. $187.7 Mn in 2024, $209.2 Mn in 2025 and $557.3 Mn in 2034, 11.5% CAGR.
Europe Biological Age Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Europe Biological Age Testing Market Dynamics

Market Growth Drivers

An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.

Opportunity

Preventive care, personalised plans based on biomarkers and home-based services give the biological Age Testing market room to grow, especially in fast-ageing countries in Asia and Europe.

Market Restraints

Limited clinical proof for some longevity products, high out-of-pocket costs, regulation that does not treat ageing as a disease and uneven access hold back the biological Age Testing market.

Competitive Landscape for Biological Age Testing Market in Europe

The biological Age Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Biological Age Testing Market in Europe

Biological Age Testing in Europe: rules, payment and research

In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first.⁠[1] In the countries we cover here, medical devices are regulated by ANSM (France)⁠[2], BfArM (Germany)⁠[3], Ministry of Health (Italy)⁠[4], Roszdravnadzor (Russia)⁠[5], AEMPS (Spain)⁠[6] and MHRA (UK)⁠[7]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.⁠[8] ClinicalTrials.gov lists 29 studies on Biological Age Testing that are recruiting, active or about to start in Europe.⁠[9]

[1] European Commission, medical devices. Checked 14 Nov 2026.

[2] ANSM, French medicines agency. Checked 14 Nov 2026.

[3] Federal Institute for Drugs and Medical Devices (BfArM). Checked 14 Nov 2026.

[4] Italian Ministry of Health. Checked 14 Nov 2026.

[5] Roszdravnadzor. Checked 14 Nov 2026.

[6] Spanish Agency of Medicines and Medical Devices (AEMPS). Checked 14 Nov 2026.

[7] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.

[8] European Commission, health technology assessment. Checked 14 Nov 2026.

[9] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how biological Age Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Europe.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Biological Age Testing right now, from free public sources.

Clinical trials

29 active trials in UK, Germany, France, Italy, Spain and Russia

Recruiting, about to start, or running now. Counted across the 6 countries we report on in Europe.

Top trial sponsors (worldwide)

  1. Longevity Metrics, Inc. 3 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Nutraland USA, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Elysium Health 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 15 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Biological Age Testing in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Biological Age Testing market in Europe?
Placeholder estimate: about $209.2 Mn in 2025, rising to about $557.3 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Biological Age Testing market in Europe growing?
Placeholder estimate: about 11.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Biological Age Testing market report cover?
The report splits the market by test (Epigenetic Clocks, Blood Biomarker Panels, Telomere Tests, Multi-Omic Tests), channel (Direct-to-Consumer, Clinics, Research) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Biological Age Testing market?
Key players include TruDiagnostic, Tally Health, InsideTracker, GlycanAge and Elysium Health.
What is driving the Biological Age Testing market?
An ageing population, longer life expectancy, rising interest in healthy ageing and new science on how the body ages are driving the biological Age Testing market. Older adults and their families are spending more on staying active and independent.
Who regulates Biological Age Testing in Europe?
In the EU, medical devices need CE marking under the Medical Device Regulation (MDR); for most devices, an independent notified body checks them first. Source: European Commission, medical devices. Checked 14 Nov 2026.
How is healthcare paid for in Europe?
Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines. Source: European Commission, health technology assessment. Checked 14 Nov 2026.
How many clinical trials on Biological Age Testing are running in Europe?
29 studies are recruiting, active or about to start in Europe, counted across the 6 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Europe. Retrieved 12 Nov 2026.
How much research is published on Biological Age Testing?
PubMed lists 803 papers on Biological Age Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Europe

See all

Related on geriatric and genomics

See the topic